ADA Scientific Sessions 2025 Abstract

Real-World Effectiveness of Finerenone in Indian Patients with Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)

By Sonali A. Patange, Dakshata Padhye

Study in peopleInterventions

The paper

Sonali A. Patange, Dakshata Padhye

Mumbai

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, poster 841-P

doi.org/10.2337/db25-841-p

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease